Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
NTLA US​

Intellia Therapeutics, Inc.(NTLA US)

$11.21+0.050.45%Ext:$11.30+0.090.80%(Market Closed · 23:55:51 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income Statement

Balance SheetCash Flow
Millions USD (ex. Per Share)
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue36.357.967.766.1
-Cost of Revenue9.010.315.987.2
Gross Profit27.347.651.7-21.1
-Operating Expenses542.6581.9492.7399.6
+Selling, General & Admin116.5125.8119.8141.4
+General And Administrative Expenses116.5125.8119.8125.6
+Research and Development435.1466.3388.9361.2
+Other Operating Expenses-9.0-10.3-15.9-103.0
Operating Income-515.3-534.3-441.0-420.7
+Non Operating Income83.963.057.551.9
+Interest Income, Net49.847.829.225.8
+Interest Income49.847.829.225.8
-Interest Expense----
+Other Non-Op Income34.115.228.326.1
Pretax Income-481.2-519.0-412.7-394.6
-Income Tax Expense----
Income from Cont Ops-481.2-519.0-412.7-394.6
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI-481.2-519.0-412.7-394.6
-Minority Interests----
Net Income, GAAP-481.2-519.0-412.7-394.6
-Prfrrd Div & Other----
Net Income Avail To Common-481.2-519.0-412.7-394.6
Weighted Average Shs Out88,770,000.098,849,000.0108,376,000.0440,786,000.0
EPS-5.4-5.3-3.8-3.5
Weighted Average Shs Out Dil88,770,000.098,849,000.0108,376,000.0440,786,000.0
EPS Diluted-5.4-5.3-3.8-3.5